⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Dr. David Berman to Join Moderna as Chief Development Officer
accessnewswire.com
MRNA
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
globenewswire.com
MRNA
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
accessnewswire.com
MRNA
Influenza Vaccine Market Poised to Reach $30.77 Billion by 2035 | Astute Analytica
globenewswire.com
SNY
MRNA
PFE
CSL
Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026"
prnewswire.com
AZN
NVS
MRNA
GILD
NVO
PFE
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
GDX
YQQQ
Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
prnewswire.com
ONCY
CHRS
MRNA
VIR
MRK
Clarametyx Biosciences Strengthens Scientific Advisory Board With Expert Appointments to Advance Pipeline Programs
businesswire.com
PFE
MRNA
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board
businesswire.com
RMD
MRNA
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
accessnewswire.com
MRNA